23.90
+1.20
+(5.29%)
As of 11:43:59 AM GMT+8. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
467,750
467,750
440,460
529,065
587,612
Cost of Revenue
386,638
386,638
368,983
446,504
487,072
Gross Profit
81,112
81,112
71,477
82,561
100,540
Operating Expense
142,673
142,673
135,853
164,790
190,554
Operating Income
-61,561
-61,561
-64,376
-82,229
-90,014
Net Non Operating Interest Income Expense
2,210
2,210
2,815
1,248
871
Pretax Income
-49,680
-49,680
-56,824
-76,499
-87,460
Tax Provision
--
--
--
-12
--
Net Income Common Stockholders
-48,531
-48,531
-55,039
-74,200
-86,420
Diluted NI Available to Com Stockholders
-48,531
-48,531
-55,039
-74,200
-86,420
Basic EPS
-1.49
--
-1.69
-2.28
-2.66
Diluted EPS
-1.49
--
-1.69
-2.28
-2.66
Basic Average Shares
32,571.14
--
32,567.46
32,546
32,546
Diluted Average Shares
32,571.14
--
32,567.46
32,546
32,546
Total Expenses
529,311
529,311
504,836
611,294
677,626
Net Income from Continuing & Discontinued Operation
-48,531
-48,531
-55,039
-74,200
-86,420
Normalized Income
-48,531
-48,531
-55,039
-74,200
-86,420
Interest Income
2,417
2,417
2,897
1,482
1,259
Interest Expense
207
207
82
234
388
Net Interest Income
2,210
2,210
2,815
1,248
871
EBIT
-49,473
-49,473
-56,742
-76,265
-87,072
EBITDA
-34,717
-34,717
-41,711
-55,350
-62,895
Reconciled Cost of Revenue
386,638
386,638
368,983
446,504
487,072
Reconciled Depreciation
14,756
14,756
15,031
20,915
24,177
Net Income from Continuing Operation Net Minority Interest
-48,531
-48,531
-55,039
-74,200
-86,420
Normalized EBITDA
-34,717
-34,717
-41,711
-55,350
-62,895
Tax Rate for Calcs
--
--
--
0
--
12/31/2021 - 12/31/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4130.TWO Genovate Biotechnology Co., Ltd.
20.55
+2.24%
3118.TWO Level Biotechnology Inc.
31.60
+1.77%
3176.TWO Medigen Biotechnology Corp.
29.10
+4.68%
4168.TWO GlycoNex Incorporation
17.05
+3.65%
6492.TWO Senhwa Biosciences, Inc.
33.40
+1.98%
1777.TWO SYN-TECH Chem. & Pharm. Co., Ltd.
88.50
+1.26%
4728.TWO Sunmax Biotechnology Co., Ltd.
388.00
+1.44%
4162.TWO PharmaEngine, Inc.
89.70
+5.41%
4131.TWO NeoCore Technology Co., Ltd.
32.55
+0.77%
6535.TWO Lumosa Therapeutics Co., Ltd.
161.50
+0.94%